Lilly’s Foundayo Pill Launches Strong: 1,400 Prescriptions in Week 1
Eli Lilly’s new GLP-1 pill shows strong early demand, big weight loss benefits, and promising heart & diabetes results.
NOTRELOAD AI
Greenland Greenlights Tanbreez Rare Earth Project as Critical Metals Takes 92.5% Control
Greenland approved a mining licence change for Tanbreez. Critical Metals nears 92.5% ownership; rare earth project grows.
Forager Capital Offers $4.80 Cash to Buy Repay Holdings
Forager offers to buy Repay Holdings for $4.80/share in cash, a 75% premium, aiming to take the company private quickly.
Apple's iPhone Shipments Surge 20% in China Despite Market Decline
Apple and Huawei grew in China’s weak phone market; others fell due to high costs and price hikes, especially Xiaomi.
Morgan Stanley Predicts PDD Stock Rise After “Ghost Takeaway” Penalty Clears
Morgan Stanley sees PDD rising short term as China’s penalty news removes uncertainty, calling it a possible near-term boost.
Kura Oncology Stock Surges as Darlifarib + Cabozantinib Shows Strong Results in Tough Kidney Cancer Cases
Kura Oncology’s combo drug shrank kidney tumors in early trial, controlled cancer in most patients, stock jumped.